Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Growth Hormone Release Pathway (GH Release Pathway)
- Target
- GH Release Pathway
- Molecular classification
- Neuroendocrine pathway, Signaling pathway, Hormone signaling
01
Overview
The growth hormone (GH) release pathway is a complex neuroendocrine system that regulates the synthesis, secretion, and action of growth hormone. It involves the hypothalamus, pituitary gland, and peripheral tissues, with key players including growth hormone-releasing hormone (GHRH), somatostatin, ghrelin, growth hormone, and insulin-like growth factor 1 (IGF-1). The pathway is crucial for growth, metabolism, and body composition, and its dysregulation is implicated in various diseases.
- Other names
- Growth hormone axisGH signaling pathwayGHRH pathwaySomatotropic axis
02
Mechanism of action
Varies depending on the specific drug: - Somatropin: Replaces or supplements endogenous GH. - Somatostatin analogs: Inhibit GH secretion. - GHRH analogs: Stimulate GH secretion. - Ghrelin receptor agonists: Stimulate GH secretion via the ghrelin receptor. - Dopamine agonists: Can suppress GH secretion in certain pituitary adenomas.
03
Biological functions
Growth regulationMetabolism regulationBody compositionAnabolic effectsCell proliferationCell differentiationHormone secretionSignal transduction
04
Disease associations
Growth disorders (e.g., dwarfism, gigantism, acromegaly)Metabolic disorders (e.g., diabetes, obesity)Age-related decline in GH secretionCachexiaSarcopenia
05
Safety considerations
Acromegaly (excess GH)GH deficiencyDrug-related side effects (e.g., edema, joint pain, carpal tunnel syndrome with somatropin)Tumor growth (potential concern with GH stimulation)Cardiovascular effectsInsulin resistance
06
Interacting drugs
Somatropin (recombinant GH)
4 more in the full profile.
07
Biomarkers
Growth hormone (GH) levelsInsulin-like growth factor 1 (IGF-1) levelsGrowth hormone-binding protein (GHBP)IGFBP-3 levels
Beyond the preview
Go deeper on Growth Hormone Release Pathway (GH Release Pathway).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Growth Hormone Release Pathway (GH Release Pathway).